Frequently Asked Questions about Bluejay Diagnostics, Inc. (BJDX)

Name: Bluejay Diagnostics, Inc. (BJDX) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Bluejay Diagnostics, Inc. (BJDX) do?

Accepted Answer

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers the Symphony platform, a technology platform comprising the Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and th...

Question 2

Is Bluejay Diagnostics, Inc. (BJDX) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of BJDX reveals an Altman Z-Score of -10.13 and a Piotroski F-Score of 1/9. These metrics, combined with its 5-year revenue trend ($0.00B most recent), help investors decide if BJDX fits their risk profile.

Question 3

What is the current P/E ratio for BJDX?

Accepted Answer

As of the latest trading session, Bluejay Diagnostics, Inc. (BJDX) has a trailing P/E ratio of -0.13.

Question 4

Who is the CEO of Bluejay Diagnostics, Inc.?

Accepted Answer

The current Chief Executive Officer of Bluejay Diagnostics, Inc. is Indranil Dey.

Question 5

What was BJDX's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Bluejay Diagnostics, Inc. reported annual revenues of $0.00B (2025), $0.00B (2024), $0.00B (2023), $0.00B (2022), $0.00B (2021) respectively.

Question 6

Does BJDX pay a dividend?

Accepted Answer

Bluejay Diagnostics, Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does BJDX have?

Accepted Answer

In its latest reporting period, Bluejay Diagnostics, Inc. generated $-0.01B in Free Cash Flow against a total debt load of $0.00B.

Question 8

What is the Price-to-Book (P/B) ratio of Bluejay Diagnostics, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Bluejay Diagnostics, Inc. (BJDX) is currently 0.15.

Question 9

What is the Price-to-Sales (P/S) ratio of BJDX?

Accepted Answer

Based on trailing twelve-month data, Bluejay Diagnostics, Inc. (BJDX) trades at a Price-to-Sales (P/S) ratio of 0.00.

Question 10

What is Bluejay Diagnostics, Inc.'s Return on Equity (ROE)?

Accepted Answer

Bluejay Diagnostics, Inc. (BJDX) has a Return on Equity (ROE) of -145.52%, representing its profitability relative to shareholder equity.